Ladenburg Thalmann Financial Services’s Opus Genetics IRD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRD
APA
Ladenburg Thalmann Financial Services's IRD Position: Q4 2019 in Review
Ladenburg Thalmann Financial Services reduced its Opus Genetics (IRD) stake by 37% in Q4 2019, selling an estimated $53 and leaving 12 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5535.
Ladenburg Thalmann Financial Services first reported a position in IRD in Q2 2014 and has held it in 23 quarters since. The position peaked at $15K in Q2 2014. 17 funds tracked by Wall St. Rank hold IRD as of Q4 2019.
- Ladenburg Thalmann Financial Services held 12 shares of Opus Genetics worth $0 as of Q4 2019.
- Ladenburg Thalmann Financial Services sold 7 Opus Genetics shares in Q4 2019, an estimated $53.
- Opus Genetics made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5535 holding.
- Ladenburg Thalmann Financial Services first reported a position in Opus Genetics in Q2 2014 and has held it in 23 quarters since.
- Ladenburg Thalmann Financial Services's Opus Genetics position peaked at $15K in Q2 2014.
- 17 funds tracked by Wall St. Rank held Opus Genetics as of Q4 2019.
Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.